Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: Insights from PARADIGM-HF
29 August 2022 (11:15 - 12:00)
Organised by:
Abstract
Slides
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
7 More presentations in this session
Doctor J. Borges-Rosa (Coimbra, PT)
Prognostic value of estimating appendicular muscle mass in heart failure using creatinine/cystatin C
Doctor T. Sunayama (Tokyo, JP)
Access the full session
The Event
ESC Congress 2022
29 August 2022
11:15 CET
